237 related articles for article (PubMed ID: 22568905)
1. Targeting nanoparticles to dendritic cells for immunotherapy.
Cruz LJ; Tacken PJ; Rueda F; Domingo JC; Albericio F; Figdor CG
Methods Enzymol; 2012; 509():143-63. PubMed ID: 22568905
[TBL] [Abstract][Full Text] [Related]
2. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.
Hamdy S; Haddadi A; Hung RW; Lavasanifar A
Adv Drug Deliv Rev; 2011 Sep; 63(10-11):943-55. PubMed ID: 21679733
[TBL] [Abstract][Full Text] [Related]
3. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
Klippstein R; Pozo D
Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
[TBL] [Abstract][Full Text] [Related]
5. Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy.
Cruz LJ; Rueda F; Cordobilla B; Simón L; Hosta L; Albericio F; Domingo JC
Mol Pharm; 2011 Feb; 8(1):104-16. PubMed ID: 21121669
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
Acharya AP; Clare-Salzler MJ; Keselowsky BG
Biomaterials; 2009 Sep; 30(25):4168-77. PubMed ID: 19477505
[TBL] [Abstract][Full Text] [Related]
7. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG
Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651
[TBL] [Abstract][Full Text] [Related]
8. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
Cruz LJ; Tacken PJ; Fokkink R; Joosten B; Stuart MC; Albericio F; Torensma R; Figdor CG
J Control Release; 2010 Jun; 144(2):118-26. PubMed ID: 20156497
[TBL] [Abstract][Full Text] [Related]
9. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
10. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
11. Particulate vaccines: on the quest for optimal delivery and immune response.
De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
[TBL] [Abstract][Full Text] [Related]
12. Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
Reddy ST; Swartz MA; Hubbell JA
Trends Immunol; 2006 Dec; 27(12):573-9. PubMed ID: 17049307
[TBL] [Abstract][Full Text] [Related]
13. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
Tacken PJ; Figdor CG
Semin Immunol; 2011 Feb; 23(1):12-20. PubMed ID: 21269839
[TBL] [Abstract][Full Text] [Related]
14. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
[TBL] [Abstract][Full Text] [Related]
15. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Elamanchili P; Diwan M; Cao M; Samuel J
Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402
[TBL] [Abstract][Full Text] [Related]
16. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
[TBL] [Abstract][Full Text] [Related]
17. Liposomal vaccines--targeting the delivery of antigen.
Altin JG; Parish CR
Methods; 2006 Sep; 40(1):39-52. PubMed ID: 16997712
[TBL] [Abstract][Full Text] [Related]
18. Mannosylated liposomes for targeted vaccines delivery.
Vyas SP; Goyal AK; Khatri K
Methods Mol Biol; 2010; 605():177-88. PubMed ID: 20072881
[TBL] [Abstract][Full Text] [Related]
19. Targeting antigens to dendritic cells in vivo.
Tacken PJ; Torensma R; Figdor CG
Immunobiology; 2006; 211(6-8):599-608. PubMed ID: 16920498
[TBL] [Abstract][Full Text] [Related]
20. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
